Broad Sky Partners, a private equity firm specializing in middle market business services and consumer companies, has announced a significant strategic investment from Capital Constellation. Concurrent with this investment, Broad Sky has completed its first acquisition, purchasing Thomas Scientific, a leading provider of critical supplies to the scientific community.
Broad Sky Partners: A Differentiated Approach to Investing
Led by CEO Tyler Zachem, a 29-year private equity veteran, Broad Sky Partners differentiates itself through sector-focused, thematic investing and value creation. Zachem, formerly Co-Head of Carlyle Global Partners, rejoined Broad Sky in 2014 to build the firm alongside partners Adam Glucksman, Jodi Kahn, and Jonathan Marlow. This experienced team leverages a deep sector focus and a dedicated Portfolio Resource Group to support portfolio companies.
“Broad Sky’s foundation is built on the strength of its people and the power of its connections,” said Zachem. “Our team of 23 professionals offers diverse talent and perspectives, including a highly experienced investment team and a robust Portfolio Resource Group. We are committed to being a great partner to all our constituents.”
Capital Constellation’s Strategic Investment
Capital Constellation, a collective of leading global institutional investors managed by Wafra Inc., has made a strategic investment in Broad Sky Partners. This investment provides Broad Sky with significant capital and expertise to further its growth trajectory.
Daniel Adamson, President of Constellation, stated, “We are excited to partner with Broad Sky. They bring a wealth of sector-focused experience and a vision to build a world-class firm.” Gustavo Cardenas, Managing Director at Wafra, added, “Broad Sky’s cohesive team is well-positioned to execute within the business services and consumer industries. We are enthusiastic about being a long-term partner.”
Constellation’s investment aligns with its strategy of supporting investor entrepreneurs and accelerating business development through collaboration among institutional investors and investment managers.
Thomas Scientific: Broad Sky’s First Acquisition
Thomas Scientific, acquired from Carlyle, represents Broad Sky’s inaugural investment. As a leading provider of essential supplies to the healthcare, biotech, clinical diagnostics, and life sciences industries, Thomas Scientific is poised for continued growth.
Charles Simmons, President & CEO of Thomas Scientific, expressed enthusiasm for the partnership, noting, “We are excited to partner with Broad Sky for our next phase of expansion. Their skills and resources will help us advance our mission to be the most trusted partner in science.”
Growth Opportunities in Life Sciences and Diagnostics
Broad Sky Partner Adam Glucksman highlighted the significant growth drivers in the life sciences and clinical diagnostics sectors. “Thomas Scientific has a platform uniquely positioned for expansion through organic growth and strategic acquisitions. We are thrilled to partner with their talented management team and support their scaling efforts.”
Lynn Calpeter, a Broad Sky Operating Partner and former General Electric finance executive, will chair Thomas Scientific’s board. Berenson & Co. served as financial advisor, and Morrison Cohen LLP acted as legal advisor to Broad Sky.
Conclusion: A Strong Start for Broad Sky Partners
The strategic investment from Capital Constellation and the acquisition of Thomas Scientific mark a strong beginning for Broad Sky Partners. With a seasoned leadership team, a focused investment strategy, and the backing of prominent institutional investors, Broad Sky is well-positioned to capitalize on opportunities in the middle market business services and consumer sectors. The firm’s commitment to partnership and value creation underscores its potential for long-term success.
